Cambridge, MA, United States of America

Chonghui Zhang

This inventor holds 1 USPTO granted patent. Top assignee: Novartis Pharma Ag. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chonghui Zhang. Retrieved from https://idiyas.com/inventor/chonghui-zhang-bdyu4yom

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Chonghui Zhang

Introduction

Chonghui Zhang is a prominent inventor based in Cambridge, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of chimeric antigen receptor-expressing cells. His work has the potential to advance therapeutic strategies in cancer treatment.

Latest Patents

Chonghui Zhang holds a patent titled "Methods of Making Chimeric Antigen Receptor-Expressing Cells." This patent represents a crucial step in the innovation of cell-based therapies, showcasing his expertise and commitment to improving medical outcomes.

Career Highlights

Zhang is currently employed at Novartis Pharma AG, a leading global healthcare company. His role at Novartis allows him to collaborate with other experts in the field and contribute to groundbreaking research and development.

Collaborations

Throughout his career, Chonghui Zhang has worked alongside notable colleagues, including Louise Mary Treanor and Michael R. Greene. These collaborations have fostered an environment of innovation and have led to advancements in their shared field of research.

Conclusion

Chonghui Zhang's contributions to biotechnology and his innovative patent work exemplify the impact of dedicated inventors in the medical field. His ongoing efforts at Novartis Pharma AG continue to push the boundaries of what is possible in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…